These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34384156)

  • 21. Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL leukemia.
    Olson KC; Kulling PM; Olson TL; Tan SF; Rainbow RJ; Feith DJ; Loughran TP
    Cancer Biol Ther; 2017 May; 18(5):290-303. PubMed ID: 27715403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients.
    Barilà G; Grassi A; Cheon H; Teramo A; Calabretto G; Chahal J; Vicenzetto C; Almeida J; Shemo BC; Shi M; Gasparini VR; Munoz-Garcia N; Pastoret C; Nakazawa H; Oshimi K; Sokol L; Ishida F; Lamy T; Orfao A; Morice WG; Loughran TP; Semenzato G; Zambello R
    Blood; 2023 Mar; 141(9):1036-1046. PubMed ID: 36096473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed-phenotype large granular lymphocytic leukemia: a rare subtype in the large granular lymphocytic leukemia spectrum.
    Neff JL; Rangan A; Jevremovic D; Nguyen PL; Chiu A; Go RS; Chen D; Morice WG; Shi M
    Hum Pathol; 2018 Nov; 81():96-104. PubMed ID: 29949739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).
    Sanikommu SR; Clemente MJ; Chomczynski P; Afable MG; Jerez A; Thota S; Patel B; Hirsch C; Nazha A; Desamito J; Lichtin A; Pohlman B; Sekeres MA; Radivoyevitch T; Maciejewski JP
    Leuk Lymphoma; 2018 Feb; 59(2):416-422. PubMed ID: 28633612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia.
    Cheon H; Xing JC; Moosic KB; Ung J; Chan VW; Chung DS; Toro MF; Elghawy O; Wang JS; Hamele CE; Hardison RC; Olson TL; Tan SF; Feith DJ; Ratan A; Loughran TP
    Blood; 2022 May; 139(20):3058-3072. PubMed ID: 35015834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic
    Savola P; Brück O; Olson T; Kelkka T; Kauppi MJ; Kovanen PE; Kytölä S; Sokka-Isler T; Loughran TP; Leirisalo-Repo M; Mustjoki S
    Haematologica; 2018 Feb; 103(2):304-312. PubMed ID: 29217783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell large granular lymphocytic (LGL) leukemia consists of CD4
    Kuwahara N; Kodaka T; Zushi Y; Sasaki M; Goka T; Maruoka H; Aoyama Y; Tsunemine H; Yamane T; Kobayashi J; Kawakami T; Ishida F; Itoh T; Takahashi T
    J Clin Exp Hematop; 2019; 59(4):202-206. PubMed ID: 31866622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.
    Kawakami F; Kawakami T; Yamane T; Maruyama M; Kobayashi J; Nishina S; Sakai H; Higuchi Y; Hamanaka K; Hirokawa M; Nakao S; Nakazawa H; Ishida F
    Int J Hematol; 2022 Jun; 115(6):816-825. PubMed ID: 35275353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
    Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
    Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
    Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
    Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8
    Huuhtanen J; Bhattacharya D; Lönnberg T; Kankainen M; Kerr C; Theodoropoulos J; Rajala H; Gurnari C; Kasanen T; Braun T; Teramo A; Zambello R; Herling M; Ishida F; Kawakami T; Salmi M; Loughran T; Maciejewski JP; Lähdesmäki H; Kelkka T; Mustjoki S
    Nat Commun; 2022 Apr; 13(1):1981. PubMed ID: 35411050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders.
    Semenzato G; Calabretto G; Teramo A; Gasparini VR; Rampazzo E; Barilà G; Zambello R
    Blood Cancer J; 2024 Jan; 14(1):13. PubMed ID: 38238319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of sensitive and quantitative STAT3 mutation analysis using next-generation sequencing in T-cell large granular lymphocytic leukemia.
    Kristensen T; Larsen M; Rewes A; Frederiksen H; Thomassen M; Møller MB
    J Mol Diagn; 2014 Jul; 16(4):382-92. PubMed ID: 24797340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series.
    Lobbes H; Dervout C; Toussirot E; Felten R; Sibilia J; Wendling D; Gombert B; Ruivard M; Grobost V; Saraux A; Cornec D; Verhoeven F; Soubrier M
    Semin Arthritis Rheum; 2020 Oct; 50(5):1109-1113. PubMed ID: 32920324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3.
    Park S; Yun J; Choi SY; Jeong D; Gu JY; Lee JS; Seong MW; Chang YH; Yun H; Kim HK
    Sci Rep; 2023 May; 13(1):7280. PubMed ID: 37142644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
    Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
    PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia.
    Bhattacharya D; Teramo A; Gasparini VR; Huuhtanen J; Kim D; Theodoropoulos J; Schiavoni G; Barilà G; Vicenzetto C; Calabretto G; Facco M; Kawakami T; Nakazawa H; Falini B; Tiacci E; Ishida F; Semenzato G; Kelkka T; Zambello R; Mustjoki S
    Blood Cancer J; 2022 Feb; 12(2):31. PubMed ID: 35210405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The clinical and laboratory characteristics of T cell large granular lymphocyte leukemia].
    Zhao X; Zhou K; Wang HJ; Zhang L; Liu QG; Jing LP; Li HQ; Yang DL; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2009 Mar; 30(3):179-82. PubMed ID: 19642367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a
    Mariotti B; Calabretto G; Rossato M; Teramo A; Castellucci M; Barilà G; Leoncin M; Vicenzetto C; Facco M; Semenzato G; Bazzoni F; Zambello R
    Haematologica; 2020 May; 105(5):1351-1360. PubMed ID: 31467122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution.
    Rivero A; Mozas P; Jiménez L; López-Guerra M; Colomer D; Bataller A; Correa J; Rivas-Delgado A; Bastidas G; Baumann T; Martínez-Trillos A; Delgado J; Giné E; Campo E; López-Guillermo A; Villamor N; Magnano L; Matutes E
    Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.